The single cell immunogenomic landscape after neoadjuvant immunotherapy combined chemotherapy in esophageal squamous cell carcinoma - Wang, Zheyi; Zhao, Yue; Wo, Yang; Peng, Yizhou; Hu, Weilei; Wu, Zhigang; Liu, Pengcheng; Shang, Yan; Liu, Chunnan; Chen, Xiao; Huang, Kan; Chen, Yuting; et al. (Cancer letters, 2024)
Keywords: Aged; Antineoplastic Combined Chemotherapy Protocols - pharmacology; Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Chemokine CXCL13 - genetics; Chemokine CXCL13 - metabolism; Esophageal Neoplasms - drug therapy; Esophageal Neoplasms - genetics; Esophageal Neoplasms - immunology; Esophageal Neoplasms - pathology; Esophageal Neoplasms - therapy; Esophageal Squamous Cell Carcinoma - drug therapy; Esophageal Squamous Cell Carcinoma - genetics; Esophageal Squamous Cell Carcinoma - immunology; Esophageal Squamous Cell Carcinoma - pathology; Esophageal Squamous Cell Carcinoma - therapy; Female; Humans; Immunotherapy - methods; Leukocyte Common Antigens - genetics; Leukocyte Common Antigens - metabolism; Male; Memory T Cells - immunology; Memory T Cells - metabolism; Middle Aged; Neoadjuvant Therapy - methods; Receptors, Antigen, B-Cell - genetics; Receptors, Antigen, B-Cell - immunology; Receptors, Antigen, B-Cell - metabolism; Receptors, CXCR5 - genetics; Receptors, CXCR5 - metabolism; Single-Cell Analysis - methods; T-Lymphocytes, Regulatory - drug effects; T-Lymphocytes, Regulatory - immunology; Tumor Microenvironment - immunology